Numerous studies have associated its presence with the aggressive progression of the disease because in CLL, a proliferating tumor cell demonstrates elevated levels of CD38 expression [103,104,105], while others have linked it to early-stage disease (Rai stages 0-II) [102]. Here, CD38 is linked to neoplasm.